Small is big: growing impact of small molecule mass spectrometry in infectious disease drug development

Laura-Isobel McCall

Open source

DOI
10.1128/msphere.00860-25
Published
2026-05-26
Container
mSphere
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/msphere.00860-25,
  title = {Small is big: growing impact of small molecule mass spectrometry in infectious disease drug development},
  author = {Laura-Isobel McCall},
  year = {2026},
  journal = {mSphere},
  doi = {10.1128/msphere.00860-25},
  url = {https://doi.org/10.1128/msphere.00860-25}
}

RIS

TY  - JOUR
TI  - Small is big: growing impact of small molecule mass spectrometry in infectious disease drug development
AU  - Laura-Isobel McCall
PY  - 2026
JO  - mSphere
DO  - 10.1128/msphere.00860-25
UR  - https://doi.org/10.1128/msphere.00860-25
ER  - 

APA

McCall, L. (2026). Small is big: growing impact of small molecule mass spectrometry in infectious disease drug development. mSphere. https://doi.org/10.1128/msphere.00860-25

Source records